This is topic XKEM - STAYING STRONG in forum Micro Penny Stocks, Penny Stocks $0.10 & Under at Allstocks.com's Bulletin Board.


To visit this topic, use this URL:
http://www.allstocks.com/stockmessageboard/ubb/ultimatebb.php/ubb/get_topic/f/8/t/019478.html

Posted by imakmony2005 on :
 
DO YOUR OWN DD.
 
Posted by imakmony2005 on :
 
LL2s looking for a run here.
 
Posted by imakmony2005 on :
 
This will hit .03 to .05 in good time.
 
Posted by imakmony2005 on :
 
UP YEPPERS
 
Posted by imakmony2005 on :
 
Bids getting thicker.
 
Posted by imakmony2005 on :
 
up up up runner, put this on the radar.
 
Posted by imakmony2005 on :
 
gapping up
 
Posted by imakmony2005 on :
 
BRING ON THE BIG VOL.
 
Posted by OhhhYeah on :
 
That was some serious shake this morning... nice to see the uptick continuing as predicted!
 
Posted by imakmony2005 on :
 
ITS FLYING.
 
Posted by imakmony2005 on :
 
HERE COME THE .0160s
 
Posted by imakmony2005 on :
 
Word is getting out now.
 
Posted by imakmony2005 on :
 
SHAKER.............
 
Posted by imakmony2005 on :
 
vol getting better, bid getting loaded, lets go back up.
 
Posted by imakmony2005 on :
 
its a wild ride.
 
Posted by imakmony2005 on :
 
its a wild ride.
 
Posted by imakmony2005 on :
 
vol coming in should gap up.
 
Posted by imakmony2005 on :
 
Might be taken it back up.
 
Posted by imakmony2005 on :
 
Man the MMs are playing with this one, There jumping all over the place. Thats a good thing.
 
Posted by imakmony2005 on :
 
IF ITS A SIGN LOOK AT ALL THE 5000 TRADES.LOL
 
Posted by smalltime on :
 
I bought in * .012 What's the projection on this stock????????????
 
Posted by imakmony2005 on :
 
There just slowly picking up shares. WATCH!
 
Posted by imakmony2005 on :
 
Well its just me here but i say .03 to .05 range.
 
Posted by Slippery Wing on :
 
does this thing have any legs left?
 
Posted by OhhhYeah on :
 
LOTS of legs left
 
Posted by Steam_Ahead on :
 
Lots of legs left based on?
 
Posted by Slippery Wing on :
 
WUND taking a lot of shares...

Big spread too. 0.0121 x 0.013
 
Posted by OhhhYeah on :
 
based on accumulation that has taken place. They will never run a stock directly up.. most of the time they will let it dip several times to shake loose more shares. In addition there is still a lot of MM buying taking place at these levels... MM's arent going to buy to lose money.
 
Posted by Slippery Wing on :
 
Man, there's some serious buzz about this stock! Volume is strong, and even though the volume has fallen off the last day or two from that huge volume day a couple days ago, the PPS is holding its ground.

Something's up, IMO
 
Posted by bosox79 on :
 
This one is starting out strong, lots of volume, keep on climbing
 
Posted by bosox79 on :
 
This one is starting out strong, lots of volume, keep on climbing
 
Posted by imakmony2005 on :
 
MIGHT GET OVER .02 THIS WEEK.
 
Posted by OhhhYeah on :
 
The shakes are getting less and less and not going down as far as the past. PPS is holding ground very well considering the change in volume. There was a lot of accumulation taking place and soon we will see the real run.
 
Posted by imakmony2005 on :
 
should jump up here.
 
Posted by imakmony2005 on :
 
Your right Ohhhyeah, this one is getting accumulated, by someone.
 
Posted by Peaser01 on :
 
Rumour has it that Dr. Ramesh C. Pandey Ph.D., is getting back from Africa this weekend, look for a PR on Monday.
 
Posted by UVCLRules on :
 
Where did you hear that? Looks like this stock is gearing up for a huge PR on Monday or Tuesday
 
Posted by imakmony2005 on :
 
Gonna go anyday now.
 
Posted by imakmony2005 on :
 
Get it cheap.
 
Posted by imakmony2005 on :
 
NOTHING BUT UP SO FAR. AND LIGHT VOLUME.
 
Posted by imakmony2005 on :
 
ITS A WINNER.
 
Posted by Slippery Wing on :
 
http://www.businessdayonline.com/?c=44&a=4926
 
Posted by imakmony2005 on :
 
I think this ones to easy.
 
Posted by Slippery Wing on :
 
what's your target, ima?
 
Posted by icecold on :
 
I normally sell half of my shares at 0.014 to 0.015, and do a buyback at 0.011 to 0.0108!!! Made me a hell lot of money in past 3 days.

I am targetting atleast 0.10 soon. But I am playing with half of my holdings everyday
 
Posted by Peaser01 on :
 
.015 won't last long, here it comes!
 
Posted by imakmony2005 on :
 
This one could be HUGE just gonna flip and ride building up shares, but .06 to .10 in a few months are the right PR.
 
Posted by icecold on :
 
Added half a million today at 0.011.

I am not selling this time my shares at 0.015, having a sell at 0.02.
 
Posted by Slippery Wing on :
 
holding over the weekend I assume?
 
Posted by imakmony2005 on :
 
YOU WILL GET THAT ONE ICE.ME OH YES HOLDING.
 
Posted by icecold on :
 
Maybe I will sell half of my shares at 0.015, this time too.... and wait for a dip again.
 
Posted by wilthethrill on :
 
I think its dangerous to flip at this point. Do you think the factory would be commissioned if the company didn't get NAFDAC approval, absolutely not. I believe the company has the approval and is just waiting to release it with hopefully some figures. We should all thank sites like these we got this news ahead of time. So far Southpick guys predictions are right on could possibly see .26 cents easily in the near future.
 
Posted by imakmony2005 on :
 
STRONG CLOSE.
 
Posted by OhhhYeah on :
 
I left for an appointment and this thing was down.. I was starting the wonder if I should of bought back the shares I flipped yesterday at .0144 (bought back at .0110)Now I am glad I did... It should be a nice ride from here since close was at .015 with Bid and Ask being the same!
 
Posted by coolnwo on :
 
.05 is not out of questions. I am hearing the official PR out Monday or Tuesday with this news.


http://www.businessdayonline.com/?c=44&a=4926
 
Posted by mr money on :
 
XKEM ---alot of accumaltion has been going the last few weeks. IMO this stock is gonna explode soon. I'm hoping for a 10 bagger from these levels short term. Been a great stock to daytrade as well, everytime it dips it goes right back up.
This news that has not been put out as a pr yet is huge!!

28 million dollar commitment from Nigerian Government, Huge biotech play, XKEM drug going in to mass production.


March 3rd, 2006
Obasanjo to launch locally produced sickle cell drug

President Olusegun Obasanjo will by June launch NIPRISAN (HEMOXIN(TM)), the locally produced drug for sickle cell disorder.
PATIENCE OGBE Abuja

The president will also use the occasion to commission Xechem International Inc. factory in the country in a move seen as a landmark investment in Nigeria. The company owns the exclusive rights to NIPRISAN

The drug NIPRISAN (HEMOXIN(TM), which is at present, undergoing final stage of registration with NAFDAC is a phyto-pharmaceutical drug for the treatment of patients suffering from Sickle Cell Disease (SCD). SCD is an insidious and painful genetic blood disorder often resulting in death at an early age.

Science and Technology Minister, Turner Isoun who disclosed this in Abuja noted that location of the factory in Nigeria would further crash the price of sickle cell drugs in Nigeria.

Isoun stated that Niprisan (HEMOXIN(TM)) was a drug cocktail, with phyto-pharmaceutical composition of four traditional plants extracted in a proprietary process. The licensor of the technology is the National Institute for Pharmaceutical Research and Development (NIPRD) in Abuja, Nigeria.

Nigeria is said to have the highest sickle cell disease population in the world ranging from four to six million representing roughly three to five percent of the country's population.

Isoun spoke at the inaugural meeting of the Ministers’ Council for the National Biotechnology Development Agency (NABDA) where he also called on the government to involve more laboratories for the control and analysis of the bird flu menace.

On the situation of bio technology in Nigeria, he called on the stockholding agencies to ensure that Nigeria benefits from the judicious and safe use of modern biotechnology.

"Biotech is a gold mine and important to this nation. Almost every Nigerian is affected by the operations of biotech. To be able to achieve all these, we will require the concerted political will and a focused leadership drive. It is therefore the collective responsibility of all of us key stakeholders of modern biotechnology to join forces in realizing this vision.

It is my belief that this collective mission will not jeopardize our separate mandates but will promote the effective coordination of our effort towards achieving the same ultimate goal."

To achieve the nation’s targets in biotech, the Director General of the National Biotechnology Development Agency (NABDA), Bamidele Solomon called for the establishment of biotechnology development fund.

The fund, he stressed, could help the nation support competent researches and be ready to tackle problems like the bird flu.

He also disclosed that Nigeria in collaboration with Trinity Biotech of the Republic of Ireland will establish a facility at SHESTCO Abuja for the production of test kits for HIV/AIDS and other diseases like HB, malaria and so on.

He added that the Federal Government has approved the sum of $28 million as counterpart commitment for the project.

He also spoke of Nigeria’s collaboration with Shantha Biotechnics Limited of India for the establishment a facility for the production of Hepatitis B vaccine and other vaccines for related diseases like typhoid, polio, DTP and related ailments.

"Government approved the sum of N10 Million in the 2004 capital budget to support carrying out of a detailed feasibility study and fulfilling other MoU requirement."
 
Posted by OhhhYeah on :
 
28 million is not for XKEM this is to invest in Biotech in general which includes HIV research Bird Flu etc.. nonetheless this stock has huge upside potential and I have been in for several weeks.
 
Posted by imakmony2005 on :
 
Getting ready for blastoff here.Dont miss the ride.
 
Posted by coolnwo on :
 
HUge day tomorrow IMO
 
Posted by 30CentRunner on :
 
Please read...

http://www.investorshub.com/boards/read_msg.asp?message_id=9998366

[Big Grin]
 
Posted by 30CentRunner on :
 
I really feel this one is going to run fast and hard.

http://www.amsterdamnews.org/News/article/article.asp?NewsID=65096&sID=20

[Big Grin]
 
Posted by 30CentRunner on :
 
At least .035 by end of week. Watch and see.

Peace [Big Grin]

.30CentRunner
 
Posted by OhhhYeah on :
 
Major breakthrough in fight against sickle cell disease
by HERB BOYD
Special to the AmNews
Originally posted 1/4/2006

With two recent victories under its belt, there is reason for optimism at Xechem, a development stage biopharmaceutical company that has been working diligently to produce and market a drug to fight against Sickle Cell Disease (SCD).
Recently, Xechem International announced that it had acquired the exclusive, worldwide licensing rights to a new five-membered heterocyclic anti-sickling compound from Virginia Commonwealth University (VCU). “Early research has shown this anti-sickling agent to be highly effective and a relatively non-toxic treatment for Sickle Cell Disease,” a press release from Xechem said. This new compound, the company stated, will further expand Xechem’s portfolio of products in its fight against this disease that is so common among Africans and African Americans.
Acquiring this compound bolsters Xechem’s portfolio, which already includes a license from the National Institute of Pharmaceutical Research and Development, Ministry of Health, Government of Nigeria, for the manufacture, marketing, and distribution of NICOSAN/HEMOXIN, an all natural, phyto-pharmaceutical product that has also shown enormous promise for SCD, according to Xechem.
NICOSAN/HEMOXIN has been granted an “Orphan Drug” status by both the U.S. Food and Drug Administration and the European Union’s regulatory body. The company is currently preparing an Investigational New Drug (IND) application for submission to the FDA and EU agencies.
''We know of no existing non-toxic medicines available anywhere in the world for the effective treatment of Sickle Cell Disease,” said Dr. Ramesh C. Pandey, Xechem's Chairman and CEO. “Between our existing product, NICOSAN™/HEMOXIN™, a non-toxic product that has shown excellent results in Phase IIA and Phase IIB clinical trials in Nigeria, and this promising new heterocyclic pharmaceutical agent being developed in collaboration with VCU, Xechem will be in a truly unique position to offer viable and efficacious treatments to patients suffering with this painful and debilitating condition.”
Along with the acquisition of the VCU licensing agreement, last week Xechem announced it had settled its anti-trust lawsuit against Bristol-Myers Squibb Company for $4.2 million. The lawsuit, filed two years ago, stemmed from Xechem’s allegations that Bristol Myers “had engaged in anti-competitive practices relating to Xechem’s efforts to manufacture and bring to market the drug paclitaxel, a generic equivalent to Bristol’s cancer drug, TAXOL ®.”
The settlement, according to Dr. Pandey, will further his company’s plans to launch its sickle cell drug. “The settlement with Bristol Myers could not have come at a better time for Xechem,” he said.
Dr. Pandey has a distinguished career in the biomedical sciences spanning over 35 years and has served with numerous universities, government agencies and pharmaceutical companies worldwide. He came to the United States from India in 1967 with a Ph.D. in medicinal chemistry and spent three post-doctorate years at the University of Illinois-Champaign Urbana, IL with Professor Kenneth L. Rinehart, Jr.
Xechem International, Inc. is a development stage biopharmaceutical company focusing on anticancer, antiviral (including AIDS), antifungal, Sickle Cell Disease, antimalarial and antibacterial products from natural sources, including microbial and marine organisms. Xechem’s mission is to bring relief to the millions of people who suffer from these diseases. Its primary focus is on the development of phyto-pharmaceuticals and other proprietary technologies, including those used in the treatment of orphan diseases. Its primary attention and resources are currently being directed toward the development and commercial launch of NICOSAN™/HEMOXIN™, which has shown efficacy in the treatment of SCD.
Sickle Cell Disease is a genetic blood disorder caused by an abnormality in the hemoglobin molecule. Patients with this disease often produce stiff, abnormally shaped cells that do not flow freely through blood vessels, creating clogs in the vessels, which in turn cut off the flow of normal hemoglobin and oxygen to the body. In Nigeria alone, according to a mini-documentary produced for Xechem by DDO Group LLC Harlem Edit, more than 25% of the population are carriers of the SCD trait and over 4.5 million Nigerians (~5% of the population) are actually afflicted with the disease. Approximately 12 million people, mostly in sub-Saharan Africa, are believed to suffer from this disease worldwide.
 
Posted by bmarley57801 on :
 
<<<<<<<<<<<HUGE>>>>>>>
 
Posted by bmarley57801 on :
 
>>>>>> H U G E <<<<<<<<<
 
Posted by IceCold on :
 
As we all predicted, this has made a aweseome start to the week !!!!!!

0.0174 already !!!
 
Posted by IceCold on :
 
As we all predicted, this has made a aweseome start to the week !!!!!!

0.0174 already !!!
 
Posted by OhhhYeah on :
 
This is great.. Between this and FMLY my account looks GREAT this morning.
 
Posted by OhhhYeah on :
 
Look at the Volume already this morning...almost 15,000,000 so far.
 
Posted by bmarley57801 on :
 
VERY NICE FLIP [Wink]
 
Posted by imakmony2005 on :
 
should get over .02 today.
 
Posted by bmarley57801 on :
 
yeah......
 
Posted by IceCold on :
 
Sold half of my shares at 0.0188, Will get in soon, if it all a shake Happens.....
 
Posted by imakmony2005 on :
 
GOING OVER .02, ICE.
 
Posted by bmarley57801 on :
 
: )
 
Posted by IceCold on :
 
Yeahhh.......... Dont remind me of that, I dont hv any shares of XKEM, unlucky me, I forgot I have put up to sell my other shares at 0.02........ I wish this would make a dip and I will get IN AGAIN .

GLTA who will be in this for a long time, I will be joining u again,
 
Posted by imakmony2005 on :
 
GOT TO LOVE WE KEEP JUMPING THE ASK.UP UP UP STILL LIGHT VOLUME TO. .03 TODAY???????
 
Posted by IceCold on :
 
A very bad for me, although I made $4K today from XKEM. Since I dont own any shares now.
 
Posted by IceCold on :
 
Lost my $1000 profit, if I would have hold on..... [Frown] ((((((((
 
Posted by imakmony2005 on :
 
OH ICE, GOING TO .03 BABY
 
Posted by imakmony2005 on :
 
JUMP IN HERE...............
 
Posted by IceCold on :
 
Hoping to get in at 0.018 atleast........ I know this one has high potential.
 
Posted by imakmony2005 on :
 
HERE WE GO BACK UP NEW HIGH COMING.
 
Posted by imakmony2005 on :
 
Tested .02 and said NO, it cant be held down forever.lol .03 coming.........
 
Posted by redgurl19 on :
 
.03 ...then .04
 
Posted by imakmony2005 on :
 
ok volume is kicking in time to rock.
 
Posted by redgurl19 on :
 
hi [Smile]
 
Posted by imakmony2005 on :
 
Whats up REDGURL.
 
Posted by bilgert on :
 
L2's show a little bit of a staring contest at .0213 and .0214. TDCM is playing with this a little...
 
Posted by imakmony2005 on :
 
TESTING .02 AGAIN, BUYING OP.
 
Posted by imakmony2005 on :
 
BET ITS FAKE.LOL
 
Posted by imakmony2005 on :
 
yep want shares better buy now! .03 is coming.
 
Posted by redgurl19 on :
 
nothing much [Smile] .03
 
Posted by redgurl19 on :
 
I hate u
 
Posted by imakmony2005 on :
 
what me?
 
Posted by imakmony2005 on :
 
GONNA TAKE OFF HERE.
 
Posted by smalltime on :
 
Mar 06, 2006 (M2 PRESSWIRE via COMTEX) -- Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Today's activity on the OTC exchange has brought Xchem International Incorporated (XKEM), and Inzon Corporation (IZON) to the attention of our research team. Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer.

Xchem International Incorporated is on the verge of a record day, rising 42% to currently trade at $.0213. The market sentiment for this relatively unknown resource company is up, having traded well over 112 million shares (at the time of publication). Something to consider is the company has not released any sort of corporate development to justify their current levels, however this does not mean the correction is not justified, it may just be a sign of things to come. Needless to say, Xchem International Incorporated is a company that we will be keeping a close watch on over the coming weeks.
 
Posted by imakmony2005 on :
 
IT IS BIGGGG!
 
Posted by djg7 on :
 
Imakmoney, this is my first post. I was able to get in during the dips today. Happy camper!!
 
Posted by zowwie438 on :
 
All,

I can't find the links again but last week I was researching Sickle Cell and Nigeria. Last year the Nigerian gov had a huge conference and they outlined their goals for 2005/2006.

In those goals... They wanted to appoint someone in office to handle such types of drugs and head up the whole pharm approval process.

Also... If you check our Doc's last name of Xchem, you will see many last names the same in gov positions over seas. Not sure if they are related, but it can't hurt. :-)

Sickle cell is some nasty stuff and here in the states it just falls by the way side because it mostly effects african americans (not much US interest from big money).... But in Nigeria, it's a whole different story.

If someone finds the link to that report, please post it... I will continue to try and find it again.

Zow
 
Posted by imakmony2005 on :
 
dig7 great buy, zowwie were just starting to run thats are DOC.
 
Posted by zowwie438 on :
 
GREAT NEWS FOR 2006!!!!

Welcome to The Cochrane Library 2006, Issue 1
the best single source of reliable evidence about the effects of healthcare


The Cochrane Library is a unique source of reliable and up-to-date information on the effects of interventions in health care. Published on a quarterly basis, The Cochrane Library is designed to provide information and evidence to support decisions taken in health care and to inform those receiving care.

For details of recent improvements to The Cochrane Library, please read this issue’s Release Notes. The Cochrane Library consists of a regularly updated collection of evidence-based medicine databases. The databases and the current numbers of records are:


They have a report on NIPRISAN from XKEM!!!

http://www.cochrane.org/reviews/en/ab004448.html

Report states:
This review found that a phytomedicine, NIPRISAN®, may be effective in reducing episodes of SCD crisis associated with severe pain

YEAH BABY!!!! This is a WIN WIN situation....

Nigeria loses almost 10,000 children a year to sickle cell. [Frown]

So if Niprisan can help reduce their pain and make us money... What more could someone wish for.

Zow
 
Posted by zowwie438 on :
 
More News:

Main results: Reports of two trials were found, of which only one, including 82 participants, was eligible for inclusion in this review. This Phase IIB (pivotal) study suggests that a phytomedicine, NIPRISAN®, was effective in reducing episodes of SCD crisis associated with severe pain over a six-month period. NIPRISAN® did not appear to affect the risk of severe complications or the level of anaemia. No serious adverse effects were reported.

Source: http://www.update-software.com/abstracts/AB004448.htm

Zow
 
Posted by imakmony2005 on :
 
Going strong and going fast, Should gap open in the morning and run EOD.
 
Posted by zowwie438 on :
 
imakmony,

Good to see you are in this one as well my friend... There is HUGE potential in XKEM and I am going to hold on to this stuff for awhile.

This spring is supposed to be big for XKEM... Lets just hope some new wierd illness doesn't come out in the future and swipe all the press coverage of their Sickle Cell efforts.

I got my fingers and toes crossed... waiting on the cramping to set in.

Zow
 
Posted by imakmony2005 on :
 
lol, ya me two.
 
Posted by imakmony2005 on :
 
Nice EOD Run, GAPPER IN THE AM.
 
Posted by djg7 on :
 
Nice run EOD!
 
Posted by wilthethrill on :
 
Google - Nigeria Sickle Cell Xechem.....lots of information and a site even has Dr. Pandey showing a model of the factory in Nigeria. Sweet.......20 cents short term target IMO.
 
Posted by zowwie438 on :
 
OMG... That was an oustanding day! :-)

WKEM 42.67% UP
RSHN 50% UP

Zow
 
Posted by IceCold on :
 
Biggest blunder of my entire life in stock was today when I released these shares today at 0.019 average and also Hesitant to buyback at 0.020 with my bid waiting at 0.019.

I had 1 million shares of this....... Lost the opportunity to make $10000 profit.... GLTA for the Rally Tomorrow morning.
 
Posted by zowwie438 on :
 
wilthethrill,

Post that link of the factory... Pls.

Zow
 
Posted by 30CentRunner on :
 
quote:
Originally posted by 30CentRunner:
At least .035 by end of week. Watch and see.

Peace [Big Grin]

.30CentRunner

[Big Grin] [Big Grin] [Big Grin] [Big Grin] [Big Grin]
 
Posted by wilthethrill on :
 
Here you go Zow!! Looks like its a pretty big facility.

http://www.nadcest.gov.ng/anemia.htm
 
Posted by zowwie438 on :
 
I love this guy!!! Check out his tie!

I like it when a business man from the United States goes to another country and sports his red, white and blues!

Talk about a power tie... It's saying "I am from the US, I am the man!" hehehe

I love body language and picking up on behavior methods.

Go XKEM!

Zow
 
Posted by zowwie438 on :
 
Well guys and gals....

Where is XKEM going to go? Looks like there are some suckers out there that are going to freak out that we are hitting a HIGH, but I am not going to let their actions scare me off.

This stuff is looking SO good right now... For the past week are so this guy as been the little engine that could. Little by little, higher and higher... Man I am so excited I could POP!

All we need is one good PR release about them moving into mass production and we are set!

Lets here some excitement guys! The RSHN thread is smoking and this one doesn't have that many posts.

Let's here some positives!

Zow
 
Posted by 30CentRunner on :
 
OK Ok,,

This is why I got into this one. A no brainer.

http://biz.yahoo.com/bw/060112/20060112005109.html?.v=1

News was great...this is what made me buy alot more at .0129

http://biz.yahoo.com/bw/060125/20060125005121.html?.v=1

Now that's friggen good news and an early sign to invest in this one!

[Big Grin]
 
Posted by imakmony2005 on :
 
SORRY I JUST THROW DARTS.LOL
 
Posted by 30CentRunner on :
 
LOL...i'm laughing on my way to the bank...LOL

I don't throw darts...'''

Hmmmmmm

Just win at Poker, Stock Picks and many girls..


LOL

[Big Grin]
 
Posted by imakmony2005 on :
 
I think thats all you do DART-BOY. LOL
 
Posted by pay up on :
 
quote:
Originally posted by 30CentRunner:
quote:
Originally posted by 30CentRunner:
At least .035 by end of week. Watch and see.

Peace [Big Grin]

.30CentRunner

[Big Grin] [Big Grin] [Big Grin] [Big Grin] [Big Grin]
quit patting yourself on the back.
You may be too low on your estimate.
try .065
 
Posted by redgurl19 on :
 
most probably
 
Posted by redgurl19 on :
 
We will see good EOD today from XKEM [Smile]
 
Posted by bilgert on :
 
Some lucky guy just got 150,000 shares at .0179 in pre-trading activities. At least I hope he's just lucky and not a harbinger of red day.
 
Posted by imakmony2005 on :
 
mine shows he payed .0250
 
Posted by redgurl19 on :
 
Yeah mine shows he paid 0.0179 [Razz]
 
Posted by redgurl19 on :
 
GAPPING HARDCORE
 
Posted by imakmony2005 on :
 
well the bids at .0270 now ha ha,lol you better check your LL2s boyz and girls.
 
Posted by redgurl19 on :
 
Good L2s!
 
Posted by imakmony2005 on :
 
filled the gap now up we go.
 
Posted by IceCold on :
 
Wait for me....... let my bid get filled at 0.02 before me move on......
 
Posted by imakmony2005 on :
 
nope were going back up......
 
Posted by imakmony2005 on :
 
And fast too.....WOW
 
Posted by imakmony2005 on :
 
Gonna gap hard, WOW
 
Posted by OhhhYeah on :
 
She is really jumping !
 
Posted by djg7 on :
 
Run!!!
 
Posted by imakmony2005 on :
 
.03 today yes with this movement.
 
Posted by redgurl19 on :
 
I know she is , i love xkem [Razz] and USXP too
 
Posted by IceCold on :
 
Good Luck........ I wish I were in this share........
 
Posted by OhhhYeah on :
 
I think many penny landers have been very fortunate recently.. usxp, clbe, jkri, xkem, jphc, idwd, vits.. and so on and so on..these have all jumped very large in the past month or so... Wonder how long all this penny momentum will last?
 
Posted by imakmony2005 on :
 
Its going to jump here.
 
Posted by redgurl19 on :
 
OhhhYEah , your not in any i believe.


Well USXP and XKEM , have good services/products. THerefore they will continue to rise .
 
Posted by OhhhYeah on :
 
see ya... Good Luck
 
Posted by redgurl19 on :
 
TYhanks [Smile]
 
Posted by OhhhYeah on :
 
lol... OK Redgurl.. I was one of the first people to have this stock a month or so ago...

1/27/2006 XKEM BOUGHT 135000 SHARES OF XKEM AT $0.0066
 
Posted by imakmony2005 on :
 
SHAKE AND THEN HERES .03 -.04 NEXT
 
Posted by imakmony2005 on :
 
YA MINES BIGGER THEN YOURs TO.
 
Posted by OhhhYeah on :
 
quote:
Originally posted by imakmony2005:
Its going to jump here.

I said See Ya .. Good Luck cause I thought your post said " I am going to jump here" my bad...
 
Posted by imakmony2005 on :
 
NICE SHAKE OUT, BYB BYB WEAKIES GOING BACK AND OVER .03.
 
Posted by imakmony2005 on :
 
LL2s look like .03 will happen on the next test.
 
Posted by OhhhYeah on :
 
Man that was a QUICK shake.. down and then right back up in a matter of minutes.
 
Posted by imakmony2005 on :
 
Here we go!!!!!!!!!! GET OVER.03
 
Posted by redgurl19 on :
 
WILL IT BREAK 0.03 IF IT DOES TOMMOROW WE SHOULD SEE 0.04 !!
 
Posted by imakmony2005 on :
 
GREAT VOLUME, IT CANT BE STOPED.HELD DOWN BUT NOT FOR LONG.
 
Posted by imakmony2005 on :
 
The MMs are loving this one, were getting stronger on the up pushes.give me .03 and start the next run to .04. SHAKE IT BOYZ!!!!!!!
 
Posted by imakmony2005 on :
 
HEADING BACK UP!
 
Posted by imakmony2005 on :
 
LOOK AT THOSE LL2s ITs HEADING UP.....
 
Posted by imakmony2005 on :
 
Gonna jump in to the .03S.
 
Posted by imakmony2005 on :
 
We have the VOLUME, now run baby run.
 
Posted by QBID'n on :
 

 
Posted by redgurl19 on :
 
Hopefully it breaks it!
 
Posted by imakmony2005 on :
 
yes i think they are and lots of others.QBIDn
 
Posted by imakmony2005 on :
 
There going to let it go soon, LETS GO! All things say RUNNER.
 
Posted by imakmony2005 on :
 
HEATING UP!
 
Posted by imakmony2005 on :
 
SHE GONNA BLOW!!!
 
Posted by imakmony2005 on :
 
SHES GONNA BLOW!!!!!
 
Posted by imakmony2005 on :
 
BIDs GETTING STRONGER, LOL, GOING OVER .03 AND HEADING FOR .04. LUNCH TIME MMs
 
Posted by bosox79 on :
 
I love this stock, its gonna hit .03 today
 
Posted by imakmony2005 on :
 
Now there making them pay for shares, OPEN THE FLOOD GATES, BIG VOLUME AFTER LUNCH.
 
Posted by imakmony2005 on :
 
Ok lets get some after lunch buying going.
 
Posted by imakmony2005 on :
 
MAN if we drop to the .0250 buy buy buy, im backing the truck up.
 
Posted by imakmony2005 on :
 
Buying op might not get much but buy it.should shoot right back up.THIS PUPPY CAN JUMP.
 
Posted by imakmony2005 on :
 
GOT MORE AT .0260.
 
Posted by djg7 on :
 
Good job imakmony! I didn't have anymore funds
available to buy more. I'm a newbie like many others here. This one has been good.

Sad day in MN. Kirby Puckett RIP!!
 
Posted by imakmony2005 on :
 
STILL IS GOOD,LOL
 
Posted by imakmony2005 on :
 
VOLUME GETTING TO 100 MILLION.
 
Posted by imakmony2005 on :
 
LIKE ALL THE 77777 TRADES GOOD LUCK TRADES.
 
Posted by redgurl19 on :
 
Good luck tradeS [Razz]
 
Posted by imakmony2005 on :
 
WELL .0250S GONNA GET MORE LOOKS LIKE 100K SHARES.
 
Posted by OhhhYeah on :
 
Man.. we can almost call you a spammer Imakmony2005 :-)

Wish this thing would quit retracing and just skyrocket :-)
 
Posted by OhhhYeah on :
 
Look at the large difference between the B/A looks like it is going UP again
 
Posted by imakmony2005 on :
 
CANT GET MY .0250s filled.
 
Posted by imakmony2005 on :
 
got em at .0250, im locked and loaded.
 
Posted by IceCold on :
 
I couldnt get this even at 0.025, i did bid on the ask, but still I wasnt able to get them.......
 
Posted by djg7 on :
 
Possible EOD run?
 
Posted by imakmony2005 on :
 
mine was in for about 2 hours
 
Posted by IceCold on :
 
Finally I got in at 0.025, after releasing this bymistake 0.020, missed out my huge 0.005 gap and half of my count in shares too.

All I wish is no more shake down.... and RollerCoaster Ride all the way UP.
 
Posted by imakmony2005 on :
 
Lets hope for the EOD RUNNER! its coming.
 
Posted by IceCold on :
 
I dont think 0.03 is easily breakable, but once it happens.... its gonna run fast to 0.04.... Hoping for that soon
 
Posted by redgurl19 on :
 
Hopefully we have a good eod !
 
Posted by imakmony2005 on :
 
LOOKING GOOD SO FAR, LL2s getting stronger for a run here.
 
Posted by imakmony2005 on :
 
Now it looks like a big shake out, Say byb byb to the weak ones.lol
 
Posted by IceCold on :
 
I need a little bit more shake-out too..... I got my some more Fill to go at 0.025 and then I can enjoy Fun ride this week...
 
Posted by redgurl19 on :
 
GO XKEM
 
Posted by imakmony2005 on :
 
The way i got this the lawsuit takes us to .04s. just that cash.
 
Posted by imakmony2005 on :
 
GREEN AGIAN, AND I SAY AM GAPPER.
 
Posted by Slippery Wing on :
 
I'm out guys.

I think the PPS will retrace a bit tomorrow, as I think it's a bit overbought. Heavy resistance at 0.029, which we saw today, and any support is down there a ways.

It is good that it closed above yesterdays range, but I see it running out of steam.

Just my opinion, of course. I could be wrong, and I wish you guys luck who are looking for a gapper tomorrow, but don't forget to take those profits!

http://stockcharts.com/c-sc/sc?s=XKEM&p=D&b=5&g=0&id=t81961850522&r=8706

-Slip
 
Posted by redgurl19 on :
 
WRong slippery wing , the pr comes out tommorow
 
Posted by Slippery Wing on :
 
Well, maybe so, but what if you're wrong?
 
Posted by redgurl19 on :
 
then im wrong , then sh oot me
 
Posted by Slippery Wing on :
 
hey, I'm just giving you my opinion. And your opinion is that you disagree with my opinion. Ok, by me.

You play with your own money, I play with mine.

My point is that I don't like to risk my gains on the speculation from anonymous message boards that a PR is going to come out. I've been burned by that too many times.

Good luck, and if it looks like it will continue, I might get back in.

-Slip
 
Posted by pay up on :
 
since this company is the first with this medication we should be in for the long with some of our shares.
 
Posted by imakmony2005 on :
 
Going up, CHASE IT AND HAVE FUN.
 
Posted by pay up on :
 


[ March 07, 2006, 21:32: Message edited by: pay up ]
 
Posted by redgurl19 on :
 
Pay up
 
Posted by imakmony2005 on :
 
let get going.
 
Posted by imakmony2005 on :
 
Time to back the truck up here. This ones not done by a long shot.IMO
 
Posted by imakmony2005 on :
 
bids getting stacked up. going up
 
Posted by djg7 on :
 
People selling today. I'm in for the long haul.
 
Posted by imakmony2005 on :
 
slow and back up.
 
Posted by imakmony2005 on :
 
Well they sure shook alot out here, now how high will we go? EOD
 
Posted by djg7 on :
 
They can shake all they want. I'm not moving! Hopefully we go to the moon!
 
Posted by imakmony2005 on :
 
IM IN BLASTOFF.GOING UP...........
 
Posted by imakmony2005 on :
 
LL2s getting better and better.
 
Posted by imakmony2005 on :
 
Gapping up.YA BABY.
 
Posted by djg7 on :
 
Keep running!!
 
Posted by imakmony2005 on :
 
gapping up .EOD RUNNER
 
Posted by imakmony2005 on :
 
WITH THIS RUN, AM GAPPER.
 
Posted by OhhhYeah on :
 
Well.. I am out. This stock was very good to me! Good Luck to you all; I hope it makes another good jump for those that are still in !
 
Posted by imakmony2005 on :
 
LL2S look good, nice shake and up same old thing this is gonna hit, .03, heading back up!
 
Posted by imakmony2005 on :
 
YEP.ARCA AT .0260s, lol
 
Posted by imakmony2005 on :
 
ok just got 100k at .0202 lets see.gonna flip it today i hpoe.
 
Posted by BULListic on :
 
In for another 100k myself...this one bounces from .02 to .024 everytime on these shakes....
 
Posted by imakmony2005 on :
 
LOOKS LIKE .02 IS BASE LOW, NOTHING BUT UPSIDE.
 
Posted by imakmony2005 on :
 
GOING UP AGIAN.........
 
Posted by redgurl19 on :
 
We will seeeeee
 
Posted by imakmony2005 on :
 
just got more.
 
Posted by imakmony2005 on :
 
RIDE THE WAVE.
 
Posted by imakmony2005 on :
 
ARCA, IS NOW AT .0269 KEEPS RISEING THERE PRICE HMM.
 
Posted by imakmony2005 on :
 
GOING BACK UP, GREAT BUY HERE.IMO
 
Posted by redgurl19 on :
 
XKEM GOING BACK UP!
 
Posted by Cerebro on :
 
New here today at 0.0181$ opinions?
 
Posted by Cerebro on :
 
rumors on <Yahoo groups Oficial News on 14th March.
 
Posted by Julia28 on :
 
Watch it...heading back to top of channel
 
Posted by Julia28 on :
 
http://investorshub.com/boards/read_msg.asp?message_id=10115770


Check this out...I like it!!!!!!!!
 
Posted by Julia28 on :
 
Thanks BB for the annotated chart
 
Posted by imakmony2005 on :
 
gapping up for the open.
 
Posted by thrillhouse1980 on :
 
Picking up momentum nicely. Looks for a good pop for lunchtime.
 
Posted by imakmony2005 on :
 
This pup can move.
 
Posted by imakmony2005 on :
 
great buy now. imo
 
Posted by thrillhouse1980 on :
 
Just broke up past 2 cents. Lots of buys coming through.
 
Posted by imakmony2005 on :
 
under .02 buy buy buy.
 
Posted by worthashot on :
 
The weak ones sold today and we still ended up green. Those holding are ready for the break-out. Go XKEM!
 
Posted by worthashot on :
 
I am so glad to be in on this one.

http://www.xechem.com/drugs.html


Always do your own D.D.
 
Posted by redgurl19 on :
 
Xechem Files Orphan Drug Application with the FDA For The Anti-Sickling Compound Licensed From Virginia Commonwealth University
Business Editors

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--March 14, 2006-- Xechem International, Inc. (OTC BB: XKEM) Xechem International announced today that it has submitted its Orphan Drug Application for the five-membered heterocyclic anti-sickling compound known as 5-HMF to the United States Food and Drug Administration (FDA).

Research Shows Efficacy of 5-HMF

As reported on December 9, 2005, this promising compound has shown excellent biological activity in preliminary testing as an anti-sickling agent. This was discovered by Prof. Donald Abraham and his team of scientists from Virginia Commonwealth University (VCU), Richmond, VA in collaboration with a team of doctors and scientists at NHLBI Sickle Cell Disease Reference Laboratory at The Children's Hospital of Philadelphia (CHOP), University of Pennsylvania led by Professor Toshio Asakura. Xechem has acquired the exclusive, worldwide rights from VCU for the production, sales and marketing of 5-HMF for use in the battle against SCD.

Research has shown that the 5-HMF compound is not only a natural product with very little if any toxicity, it also appears to be an effective anti-sickling agent which has shown high affinity for hemoglobin and is very active in genetically modified transgenic (Tg) mice. Professor Abraham of VCU has characterized this compound as "the best potential antisickling agent in 30 years research to be discovered by (VCU's) research group." See Xechem's December 9, 2005 Press Release.

If granted, Orphan Drug status will afford Xechem seven years of marketing exclusivity for the drug once the drug is ultimately approved by the FDA, and will offer Xechem tax credits, filing fee waivers and certain other statutory benefits.

5-HMF Complements Xechem's Existing Arsenal for Treatment of Sickle Cell Disease

According to Xechem's Chairman and CEO, Dr. Ramesh C. Pandey, "This new compound licensed from VCU represents the latest effort undertaken by Xechem in the fight against Sickle Cell Disease (SCD), and adds to Xechem's existing arsenal of NICOSAN(TM)/HEMOXIN(TM), an all natural, phyto-pharmaceutical product that has shown enormous promise for SCD sufferers. NICOSAN(TM)/HEMOXIN(TM) has already been designated as an Orphan Drug both in the United States and in European Union countries. It was acquired under an exclusive worldwide license from the National Institute for Pharmaceutical Research and Development (NIPRD), Ministry of Health, Government of Nigeria, Between the progress we have been making in bringing NICOSAN(TM) to market, and this exciting new heterocyclic pharmaceutical agent being developed in collaboration with VCU, we expect Xechem to be front and center in eventually offering the most viable and efficacious treatments to patients suffering with SCD around the world." Dr. Pandey added that the Company intends shortly to prepare and file an Investigational New Drug (IND) Application for submission to the FDA for both HEMOXIN(TM) and 5-HMF.

About Sickle Cell Disease

Sickle Cell Disease is a genetic blood disorder caused by an abnormality in the hemoglobin molecule. Patients with this disease often produce stiff, abnormally shaped cells that do not flow freely through blood vessels, creating clogs in the vessels, which in turn cut off the flow of normal hemoglobin and oxygen to the body. In Nigeria alone, more than 25% of the population are carriers of the SCD trait and over 4.5 million Nigerians (about 5% of the population) are actually afflicted with the disease. Approximately 15 million people, mostly in sub-Saharan Africa, are believed to suffer from this disease worldwide.

About Xechem

Xechem International, Inc. is a development stage biopharmaceutical company focusing on anticancer, antiviral (including AIDS), antifungal, Sickle Cell Disease (SCD), antimalarial and antibacterial products from natural sources, including microbial and marine organisms as well as the development of phyto-pharmaceuticals and other proprietary technologies, including those used in the treatment of orphan diseases. Xechem's mission is to bring relief to the millions of people who suffer from these diseases. Its primary attention and resources are currently being directed toward the development and commercial launch of the phyto-pharmaceutical NICOSAN(TM)/HEMOXIN(TM), which has shown efficacy in the treatment of SCD.

Forward Looking Statements

This press release contains certain forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by safe harbors created hereby. Such forward-looking statements involve known and unknown risks and uncertainties.

KEYWORD: NORTH AMERICA NEW JERSEY UNITED STATES INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL RESEARCH & SCIENCE PRODUCT/SERVICE SOURCE: Xechem International, Inc.

CONTACT INFORMATION: Xechem International, Inc. Stephen Burg, 707-425-8855
 
Posted by sportsguy on :
 
.03 today?
 
Posted by redgurl19 on :
 
Tuesday, March 14 2006 8:51 AM, EST

--------------------------------------------------------------------------------

Morning Stock Focus List for Tuesday, March 14, 2006: Submitting to the U.S. Food and Drug Administration!
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Peter Antipatis of Capital Research Group Inc.

WESTON, FL -- (MARKET WIRE) -- 03/14/06 -- ************* names the following stocks to its Stock Focus List: Xechem International Inc. (OTC BB: XKEM), NMT Medical, Inc. (NASDAQ: NMTI), The Medicines Company (NASDAQ: MDCO), Google Inc. (NASDAQ: GOOG).

Xechem International, Inc. (OTC BB: XKEM) just announced that it has submitted its Orphan Drug Application for the five-membered heterocyclic anti-sickling compound known as 5-HMF to the United States Food and Drug Administration (FDA).

As reported on December 9, 2005, this promising compound has shown excellent biological activity in preliminary testing as an anti-sickling agent. If granted, Orphan Drug status will afford Xechem seven years of marketing exclusivity for the drug once the drug is ultimately approved by the FDA, and will offer Xechem tax credits, filing fee waivers and certain other statutory benefits.

Other stocks highlighted include NMT Medical, Inc. (NASDAQ: NMTI): Stock Focus List, down 33% on 9 million shares, The Medicines Company (NASDAQ: MDCO): Stock Focus List, up 10% on 5 million shares, Google Inc. (NASDAQ: GOOG): Stock Focus List, down 1% on 15 million shares.

"A few disappointing earnings releases and some disparate economic data have done their part to stall the market's advance, and political developments abroad have kept investors cautious. But overall tame inflation numbers, though rising over the past few months, solid growth in the domestic economy, and lower unemployment are buffeting the averages from below." More is available at: http://www.*************.

*************'s Daily Stock Updates:

*************, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to http://www.*************.

All material herein was prepared by Capital Research Group, Inc. (CRG) based upon information believed to be reliable. The information contained herein is not guaranteed by CRG to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.************* or mentioned herein. CRG has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRG has been compensated thirty thousand dollars for XKEM. CRG was compensated one hundred twenty thousand dollars in past compensation for XKEM. CRG intends to sell its shares. CRG has sold approximately zero XKEM shares to date. CRG may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRG's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. CRG will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

Chuck Tamburello Phone: 954-217-8555 Fax: 954-217-1500
 
Posted by redgurl19 on :
 
0.0209x0.0201 !!!!
 
Posted by djg7 on :
 
0.0213x0.0201!
 
Posted by CTMum on :
 
This is going to be a chaser unless every one backs off the bid it's only 9:15, this is going to be insane by 9:30!!
 
Posted by thrillhouse1980 on :
 
Just started to gap. This could be a fun day.
 
Posted by imakmony2005 on :
 
see very nice open.
 
Posted by CTMum on :
 
Suprised on such big news this isn't moving that quick. I jumped in on the open not to miss the boat now my screen is all red. I think I just need to step away from the screen. I have sat back and watched this stock do some incredible things with no real news behind it. I can't imagine what it will do with todays news.
 
Posted by thrillhouse1980 on :
 
Profit takers at work. Just another opportunity to pick up some more at a good price.
 
Posted by imakmony2005 on :
 
NOW THATS A TRADER!
 
Posted by djg7 on :
 
Time to buy more!! 0.0195/0.0196!
 
Posted by topsail on :
 
just added at .0195, I'll treat this as a gift. Hope I'm right. Good luck to all.
 
Posted by CTMum on :
 
Ok now everyone had their chance to get the cheap shares, now can it go up? Pretty Please!!
 
Posted by usasail on :
 
Anybody know the OS? I seeing 9BL as of 4/2003, but with a 1/3000 RS after the 9BL publication.
TIA
Sail
 
Posted by thrillhouse1980 on :
 
block of .0195s busted. Up we go.
 
Posted by CTMum on :
 
Finally they upped the ask, I have seen the ask below last price at least twice today.
 
Posted by CTMum on :
 
It did it again, last was .002 ask went to .0198
 
Posted by redgurl19 on :
 
go up
 
Posted by CTMum on :
 
They keep lowering the ask, below the last. Last was .0194 Ask was .0193. Why!!!!!!!!!!!!!

Just venting, my dogs are sick of me yelling.
 
Posted by thrillhouse1980 on :
 
This downward pressure is getting old. Just a matter of time before the good news eariler in the day finally registers and pops us up either EOD or tommorrow morning.
 
Posted by CTMum on :
 
This stock looking back does have a tendency to bound up late in day and jump in the am. JMO
 
Posted by imakmony2005 on :
 
This stock can jump up fast, but you will not be up every day.
 
Posted by CTMum on :
 
Imaka:
History does back that up. I know I have sold this short before and kicked myslef for it. Holding on, just expected a stronger day with such strong news the the AM.
 
Posted by IceCold on :
 
Just added 100K more at 0.0171...... I could have waited for little longer to go for less price..... But I went to buy it 0.017.
 
Posted by thrillhouse1980 on :
 
Good timing Ice. Looks like the reversal is starting. upped the bid
 
Posted by CTMum on :
 
So much for EOD rally, lets hope for better things tomorrow.
 
Posted by thrillhouse1980 on :
 
Today did turn out to be not the greatest, but it looks like most of the picks got pounded today thanks to the MMs. Lets just hope for a turnaround tomorrow. It's very likly that todays news will convert into big gains tomorrow. We'll see.
 
Posted by usasail on :
 
Anybody have ideas on OS? I know I know look it up myself....well I see 9BL...what do you see?
 
Posted by pay up on :
 
it's the same story everyday.
People always think tomorrow will be better.
It will be better when there is serious news.
Until then it will have it's little ups and downs.
 
Posted by Cerebro on :
 
Pandey represents XKEM Nigeria 21st March Tuesday at 10.00am Nigerian Products After him
General Director of NAFDAC who aproved the drug speaks in the conference.

Pandey on the 21st....is the Antimalaria Meeting...
http://www.worldagroforestry.org/treesandmarkets/antimalariameeting/schedule.html
 
Posted by Cerebro on :
 
I spoke 3 hours ago with Steve Burg he tell that the company is very exceiting about that , he told he dont say no more !

I pick up more tomorrow with this discount , today shorters take control of the Stock they need to cover before the Oficial News Out !!!!!!
 
Posted by CTMum on :
 
Has the bleeding finally stopped on this one?
 
Posted by smalltime on :
 
Enter Symbol(s): Go Find Symbol

Markets Stocks Funds Bonds ETFs
****************: Issues Updates on Xechem International Incorporated


By M2
Last Update: 3/15/2006 11:09:53 AM Data provided by

Mar 15, 2006 (M2 PRESSWIRE via COMTEX) -- Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Today's activity on the OTC exchange has brought Xechem International Incorporated (XKEM) to the attention of our research team. Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer. Shares of Xechem International Incorporated slipped 5% today to $.016 while trading 22 million at the time of publication. Although the company has not released any press today, the recent activity could be a carry over from yesterday's news.

Xechem International announced yesterday that it has submitted its Orphan Drug Application for the five-membered heterocyclic anti-sickling compound known as 5-HMF to the United States Food and Drug Administration (FDA).

As reported on December 9, 2005, this promising compound has shown excellent biological activity in preliminary testing as an anti-sickling agent. This was discovered by Prof. Donald Abraham and his team of scientists from Virginia Commonwealth University (VCU), Richmond, VA in collaboration with a team of doctors and scientists at NHLBI Sickle Cell Disease Reference Laboratory at The Children's Hospital of Philadelphia (CHOP), University of Pennsylvania led by Professor Toshio Asakura. Xechem has acquired the exclusive, worldwide rights from VCU for the production, sales and marketing of 5-HMF for use in the battle against SCD.

Research has shown that the 5-HMF compound is not only a natural product with very little if any toxicity, it also appears to be an effective anti-sickling agent which has shown high affinity for hemoglobin and is very active in genetically modified transgenic (Tg) mice. Professor Abraham of VCU has characterized this compound as "the best potential antisickling agent in 30 years research to be discovered by (VCU's) research group." See Xechem's December 9, 2005 Press Release.

If granted, Orphan Drug status will afford Xechem seven years of marketing exclusivity for the drug once the drug is ultimately approved by the FDA, and will offer Xechem tax credits, filing fee waivers and certain other statutory benefits.

According to Xechem's Chairman and CEO, Dr. Ramesh C. Pandey, "This new compound licensed from VCU represents the latest effort undertaken by Xechem in the fight against Sickle Cell Disease (SCD), and adds to Xechem's existing arsenal of NICOSAN(TM)/HEMOXIN(TM), an all natural, phyto-pharmaceutical product that has shown enormous promise for SCD sufferers. NICOSAN(TM)/HEMOXIN(TM) has already been designated as an Orphan Drug both in the United States and in European Union countries. It was acquired under an exclusive worldwide license from the National Institute for Pharmaceutical Research and Development (NIPRD), Ministry of Health, Government of Nigeria, Between the progress we have been making in bringing NICOSAN(TM) to market, and this exciting new heterocyclic pharmaceutical agent being developed in collaboration with VCU, we expect Xechem to be front and center in eventually offering the most viable and efficacious treatments to patients suffering with SCD around the world." Dr. Pandey added that the Company intends shortly to prepare and file an Investigational New Drug (IND) Application for submission to the FDA for both HEMOXIN(TM) and 5-HMF
 
Posted by smalltime on :
 
Creeping back up.......
 
Posted by imakmony2005 on :
 
Anything under .02 is a BUY,IMO
 
Posted by redgurl19 on :
 
XKEM presentation next week: (below, for those that missed reading it)

XKEM March 21st meeting link:

African Antimalaria Meeting ( Nairibi, Kenya, Africa )

Pandey represents XKEM ( Nigeria ) March 21st ( 9:40am )

General Director of NAFDAC who aproved the drug speaks later that dayat the conference ( 12:20 pm )

Schedule of Events:

http://www.worldagroforestry.org/treesandmarkets/antimalariameeting/schedule.html
 
Posted by imakmony2005 on :
 
Give it time, it will pop up agian.
 
Posted by Cerebro on :
 
Alert Look this ---****************: Issues Updates on Xechem International Incorporated

Mar 15, 2006 (M2 PRESSWIRE via COMTEX) -- Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Today's activity on the OTC exchange has brought Xechem International Incorporated (OTCBB:XKEM) to the attention of our research team. Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer. Shares of Xechem International Incorporated slipped 5% today to $.016 while trading 22 million at the time of publication. Although the company has not released any press today, the recent activity could be a carry over from yesterday's news.
Xechem International announced yesterday that it has submitted its Orphan Drug Application for the five-membered heterocyclic anti-sickling compound known as 5-HMF to the United States Food and Drug Administration (FDA).

As reported on December 9, 2005, this promising compound has shown excellent biological activity in preliminary testing as an anti-sickling agent. This was discovered by Prof. Donald Abraham and his team of scientists from Virginia Commonwealth University (VCU), Richmond, VA in collaboration with a team of doctors and scientists at NHLBI Sickle Cell Disease Reference Laboratory at The Children's Hospital of Philadelphia (CHOP), University of Pennsylvania led by Professor Toshio Asakura. Xechem has acquired the exclusive, worldwide rights from VCU for the production, sales and marketing of 5-HMF for use in the battle against SCD.

Research has shown that the 5-HMF compound is not only a natural product with very little if any toxicity, it also appears to be an effective anti-sickling agent which has shown high affinity for hemoglobin and is very active in genetically modified transgenic (Tg) mice. Professor Abraham of VCU has characterized this compound as "the best potential antisickling agent in 30 years research to be discovered by (VCU's) research group." See Xechem's December 9, 2005 Press Release.

If granted, Orphan Drug status will afford Xechem seven years of marketing exclusivity for the drug once the drug is ultimately approved by the FDA, and will offer Xechem tax credits, filing fee waivers and certain other statutory benefits.

According to Xechem's Chairman and CEO, Dr. Ramesh C. Pandey, "This new compound licensed from VCU represents the latest effort undertaken by Xechem in the fight against Sickle Cell Disease (SCD), and adds to Xechem's existing arsenal of NICOSAN(TM)/HEMOXIN(TM), an all natural, phyto-pharmaceutical product that has shown enormous promise for SCD sufferers. NICOSAN(TM)/HEMOXIN(TM) has already been designated as an Orphan Drug both in the United States and in European Union countries. It was acquired under an exclusive worldwide license from the National Institute for Pharmaceutical Research and Development (NIPRD), Ministry of Health, Government of Nigeria, Between the progress we have been making in bringing NICOSAN(TM) to market, and this exciting new heterocyclic pharmaceutical agent being developed in collaboration with VCU, we expect Xechem to be front and center in eventually offering the most viable and efficacious treatments to patients suffering with SCD around the world." Dr. Pandey added that the Company intends shortly to prepare and file an Investigational New Drug (IND) Application for submission to the FDA for both HEMOXIN(TM) and 5-HMF.

To view other Market Gainer reports in this and other sectors, please visit www.**************** for a complimentary subscription to the newest and most exciting online financial newsletter on the market. This article is available for viewing in the featured articles section on our website. No Credit Card information needed.

New to the Market Gainer's website is our very own in-site blog, offering our subscribers the opportunity to communicate with fellow investors without all the spam found in other investment blogs. Click on talking stocks after you subscribe to join, and enhance your investment knowledge and community.

The Financial Information and Financial Content provided by **************** is for informational purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or endorsement, recommendations, or sponsorship of any company or security by ****************. You acknowledge and agree that any request for information is unsolicited and shall neither constitute nor be construed as investment advice by **************** to you. It is strongly recommended that you seek outside advice from a qualified securities professional prior to making any securities investment. **************** does not provide or guarantee any legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or informational source.

All material herein was prepared by based upon information believed to be reliable. The information contained herein is not guaranteed by Market Gainer to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Market Gainer is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info*m2.com.


(C)1994-2006 M2 COMMUNICATIONS LTD

-0-


Search for Dun & Bradstreet reports on this company.
 
Posted by topsail on :
 
added 200k yesterday * .016 will add more if it drops below .015. I'm calling this averaging down, not catching a falling knife. We'll see if I'm right. anyone else adding?
 
Posted by imakmony2005 on :
 
Just need the right PR today.
 
Posted by JimSC on :
 
XKEM: at 0.016 -- a great gamble.
 
Posted by JimSC on :
 
XKEM: 2nd run is coming.
Watch it.
 
Posted by imakmony2005 on :
 
IM THERE.
 
Posted by JimSC on :
 
Enjoy a great ride with the MMs,
and trust their ability to pump after
they have collected tons of cheap shares.
 
Posted by bilgert on :
 
Anybody have any target prices on this? I got a few shares of this a while ago at .0146 and held onto it during the last rally thinking it would easily crest 0.35 when it lost steam at about .027. Still think it's a good buy with a high flip potential, esp. with all the PRs on the horizon, but the MMs are really playing with this
 
Posted by JimSC on :
 
XKEM: Among last 10 trades -- 9 buys vs. 1 sale.
Strong uptrend.
 
Posted by Knuckles on :
 
WHOA!
 
Posted by Knuckles on :
 
god I hate Ameritrade
 
Posted by redgurl19 on :
 
Hopefully it does good. Im waiting.
 
Posted by imakmony2005 on :
 
Its a jumper.
 
Posted by bilgert on :
 
Does anybody (besides me) have shares of FMLY and XKEM. It's remarkable how they both move. When one moves (up or down), the other one has a similar pattern a couple of days later. Eventually things settle and they end up at the same price.
 
Posted by topsail on :
 
bilgert: Thought about getting FMLY awhile back, but went with USXP instead. It's pattern is similar as well, although it is retreating further than XKEM this time around. I'm watching both for now and plan to pick one of them up shortly.

Good Luck
 
Posted by JimSC on :
 
XKEM: 0.018 -- up 12%; great chart.
Watch it.
 
Posted by imakmony2005 on :
 
Looking good jim.
 
Posted by redgurl19 on :
 
WATCH XKEM!
 
Posted by imakmony2005 on :
 
HMM
 
Posted by redgurl19 on :
 
Just spoke with IR for XKEM...They could get ok for drug in Nigeria ANY DAY now, and with OTHER COUNTRIES to follow..This is what I thought, but was nice to confirm it...Takes longer in the US, however, once working in other countries, that could speed up process here
 
Posted by redgurl19 on :
 
XKEM GAPPER TOMMOROW
 
Posted by pay up on :
 
quote:
Originally posted by redgurl19:
XKEM GAPPER TOMMOROW

yea, just like today, yesterday and every other day.
We need some news for a gapper.
I picked up another 40,000 today hoping it flies soon. I got rid of my PAIM to buy this. This stands a better chance of coming through first.
 
Posted by Cerebro on :
 
XKEM from other board (in addition to myself talking to Stephen Burg today):

NIZ,The Govt Is Under Alot Of Pressure To Get The Drug Approved ASAP. I Talked To Steve Today And He Said The Factory Is Built And All The Supplies And Personel Are Ready To Go And That Revs Start From Day 1. All We Need Is That Green Light. The Nigerian Govt Will Pay For The Drug And Distribute It. We Are Babies Breath Away.

(Voluntary Disclosure: Position- Long; ST Rating- Strong Buy; LT Rating- Strong Buy
 
Posted by Cerebro on :
 
Xkem ----- Easy to 0.05 cents!

Under 0.02 cents good Prize !
 
Posted by redgurl19 on :
 
I believe so. It will just take time till it pops!
 
Posted by JimSC on :
 
XKEM: 0.0162 - a great gamble for next
week's PR.
 
Posted by imakmony2005 on :
 
Run baby run.
 
Posted by redgurl19 on :
 
imakmoney good good
 
Posted by imakmony2005 on :
 
oh yes
 
Posted by Cerebro on :
 
Next week XKEm ----- make me Rich pandey !!!!!!
 
Posted by Cerebro on :
 
from ragingbull--- a lot of people call to IR of XKEm .----
By: machcobra
17 Mar 2006, 04:24 PM EST
Msg. 15894 of 15903
(This msg. is a reply to 15890 by mpd68.)
Jump to msg. #
mpd, Steve told me as well all done except a couple pieces of equipment, which is really no big deal. You can be certain we will be hearing as soon as the approval comes and by the way Steve talks could be any minute. You know how that goes...
- - - - -
View Replies »

Advertisements
• Low Rate Source: $200k for $643/
 
Posted by redgurl19 on :
 
nice nice
 
Posted by Cerebro on :
 
By: backdoorbear
17 Mar 2006, 04:55 PM EST
Msg. 15904 of 15904
(This msg. is a reply to 15890 by mpd68.)
Jump to msg. #
mpd68

I can't recall his precise words, but Steve indicated that construction of the production facility has been ongoing for some time, that it is almost finished, and all that remains is to add a few items of equipment. My impression was that the key event will be the final approval of HEMOXIN, and that the facility should be ready for porduction at that time.

Advertisements
 
Posted by imakmony2005 on :
 
STILL LIKE IT AND IM IN.
 
Posted by Cerebro on :
 
XKEm Alert ------- ************* names the following
stocks to its Stock Pick List: Xechem International Inc.
(OTC BB: XKEM), Broadcom Corporation (NASDAQ: BRCM), ADC
Telecommunications (NASDAQ: ADCT): Stock Focus List, up 1%
on 4 million shares), SINA Corporation (NASDAQ: SINA).

Xechem International Inc. (OTC BB: XKEM) just announced
significant progress in its development efforts for
NICOSAN™/ HEMOXIN™, a natural product extract which shows
promise in the treatment of Sickle Cell Disease (SCD).
Xechem has an exclusive world-wide license for the
development and sale of NICOSAN™/ HEMOXIN™ from the National
Institute for Pharmaceutical Research and Development
(NIPRD), Abuja, government of Nigeria, which holds the
patent.

Other stocks highlighted include Broadcom Corporation
(NASDAQ: BRCM): Stock Watch List, down 3% on 9 million
shares, SINA Corporation (NASDAQ: SINA): Stock Watch List,
down 2% on 2 million shares, ADC Telecommunications (NASDAQ: ADCT): Stock Focus
List, up 1% on 4 million shares): Stock
Watch List, up 1% on 4 million shares.

“Stocks have been hard-pressed to pick a direction in
trading lately, going on a tear for a few days, only to see
those gains wane in the next several sessions. The Dow
Jones Industrial Average is, in fact, hovering very close to
the level it was at when the Federal Reserve began raising
rates months ago.” More is available at:
http://www.*************/sub_comm.asp.

*************’s Daily Stock Updates:

*************, a leader in corporate communications and
finance, highlights stocks that are in the news, have traded
high volume, or experienced a large change in price in
recent sessions. The aforementioned commentary is not meant
to be indicative of a “long term” view of any of the
companies listed. For more go to
http://www.*************/sub_comm.asp.
 
Posted by Cerebro on :
 
XKEM HERE!!> XKEM 500mill Revs Begining Day 1 And That Is Nigerian Govt Subsidized In Nigeria Alone!. Their Plant To Manufacture The Drug For Sicle Cell Disease (Keeps The Effects Of The Disease Greatly Suppresed And Is The Only Known One To Do So) Is Complete And All The Supplies Are Stocked To Begin. They Use 4 Locally Indigenous Plants In Manufacturing The Drug. They Are Awaiting Final Approval From The Nigerian Equivelent Of Our FDA Which Could Come Any Time Now. 450-500 Mill O/S. They Just One A 4mill Settlement Against Bristol Myers Squib Also. This Article Caught The Co By Supprise And Is Part Of The Reason For Surge In Volume. This One IS Be A Gem. From Nigerian News Paper.>

Last Updated: 17th March


March 3rd, 2006
Obasanjo to launch locally produced sickle cell drug
E-MAIL THIS PRINT THIS


President Olusegun Obasanjo will by June launch NIPRISAN (HEMOXIN(TM)), the locally produced drug for sickle cell disorder.
PATIENCE OGBE Abuja

The president will also use the occasion to commission Xechem International Inc. factory in the country in a move seen as a landmark investment in Nigeria. The company owns the exclusive rights to NIPRISAN

The drug NIPRISAN (HEMOXIN(TM), which is at present, undergoing final stage of registration with NAFDAC is a phyto-pharmaceutical drug for the treatment of patients suffering from Sickle Cell Disease (SCD). SCD is an insidious and painful genetic blood disorder often resulting in death at an early age.

Science and Technology Minister, Turner Isoun who disclosed this in Abuja noted that location of the factory in Nigeria would further crash the price of sickle cell drugs in Nigeria.

Isoun stated that Niprisan (HEMOXIN(TM)) was a drug cocktail, with phyto-pharmaceutical composition of four traditional plants extracted in a proprietary process. The licensor of the technology is the National Institute for Pharmaceutical Research and Development (NIPRD) in Abuja, Nigeria.

Nigeria is said to have the highest sickle cell disease population in the world ranging from four to six million representing roughly three to five percent of the country's population.

Isoun spoke at the inaugural meeting of the Ministers’ Council for the National Biotechnology Development Agency (NABDA) where he also called on the government to involve more laboratories for the control and analysis of the bird flu menace.

On the situation of bio technology in Nigeria, he called on the stockholding agencies to ensure that Nigeria benefits from the judicious and safe use of modern biotechnology.

"Biotech is a gold mine and important to this nation. Almost every Nigerian is affected by the operations of biotech. To be able to achieve all these, we will require the concerted political will and a focused leadership drive. It is therefore the collective responsibility of all of us key stakeholders of modern biotechnology to join forces in realizing this vision.

It is my belief that this collective mission will not jeopardize our separate mandates but will promote the effective coordination of our effort towards achieving the same ultimate goal."

To achieve the nation’s targets in biotech, the Director General of the National Biotechnology Development Agency (NABDA), Bamidele Solomon called for the establishment of biotechnology development fund.

The fund, he stressed, could help the nation support competent researches and be ready to tackle problems like the bird flu.

He also disclosed that Nigeria in collaboration with Trinity Biotech of the Republic of Ireland will establish a facility at SHESTCO Abuja for the production of test kits for HIV/AIDS and other diseases like HB, malaria and so on.

He added that the Federal Government has approved the sum of $28 million as counterpart commitment for the project.

He also spoke of Nigeria’s collaboration with Shantha Biotechnics Limited of India for the establishment a facility for the production of Hepatitis B vaccine and other vaccines for related diseases like typhoid, polio, DTP and related ailments.

"Government approved the sum of N10 Million in the 2004 capital budget to support carrying out of a detailed feasibility study and fulfilling other MoU requirement."


More In Headlines
» Capitalisation in the insurance...
» Banks to merge for external...
» Multi-purpose halls back in...
» Obi to be sworn in today
» Delta, militants in stalemate...
» pic031706
 
Posted by Cerebro on :
 
Pictures of Xechem Nigeria production facility * Shestco facility

www.SHESTCO.org

Sounds like they are ready to start production of Nicosan.June looks like the starting date IMO They are in the advanced stages of completing of this 8.5 million dollar facility.Pictures look like it's ready to go!


I've just been convinced that this is gonna roll in June.This website is just up & running I believe.We should be able to get updates from this website on Xechems progress? STRONG BUY MONDAY!!!!!!
 
Posted by redgurl19 on :
 
IM BUYN G MORE AND MORE
 
Posted by redgurl19 on :
 
GO XKEM UT
 
Posted by amer12ca on :
 
This is looking very strong here. 42M volume
 
Posted by imakmony2005 on :
 
looking up.
 
Posted by Cerebro on :
 
From : Xechem Pharmaceutical Nig. Ltd.
Sent : Tuesday, March 21, 2006 3:16 PM
To :
Subject : Re: Information

March 21, 2006.

Dear

Thank you for your e-mail of March 21, 2006.

Dr. Ramesh C. Pandey is presently attending Africa Anti Malaria Meeting in Nairobi, Kenya. He is trying to work out plans on projects like Malaria and HIV, etc. It will be premature to make any pronouncements at this moment.

Thank you and best regards.

Sincere,

Col. Bhuwan C. Pandey
 
Posted by Cerebro on :
 
XKEM.ob ...............Great oportunity to BUY Under 0.0150 cents .
HOLD HOLD HOLD this GEM ! amazing oportunity to WIN 500%.

XKEM 500mill Revs

Begining Day 1 And That Is Nigerian Govt Subsidized In Nigeria Alone!.

Their Plant To Manufacture The Drug For Sicle Cell Disease (Keeps The Effects Of The Disease Greatly Suppresed And Is The Only Known One To Do So) Is Complete And All The Supplies Are Stocked To Begin.

They Use 4 Locally Indigenous Plants In Manufacturing The Drug. They Are Awaiting Final Approval From The Nigerian Equivelent Of Our FDA Which Could Come Any Time Now. 700 Mill O/S. 30% of this his Owner ALEMBIC Big Indian Biotech.

They Just One A 4mill Settlement Against Bristol Myers Squib Also.


This Article Caught The Co By Supprise And Is Part Of The Reason For Surge In Volume. This One IS Be A Gem.

From Nigerian News Paper.>

Last Updated: 17th March


March 3rd, 2006
Obasanjo to launch locally produced sickle cell drug
E-MAIL THIS PRINT THIS


President Olusegun Obasanjo will by June launch NIPRISAN (HEMOXIN(TM)), the locally produced drug for sickle cell disorder.
PATIENCE OGBE Abuja

The president will also use the occasion to commission Xechem International Inc. factory in the country in a move seen as a landmark investment in Nigeria. The company owns the exclusive rights to NIPRISAN

The drug NIPRISAN (HEMOXIN(TM), which is at present, undergoing final stage of registration with NAFDAC is a phyto-pharmaceutical drug for the treatment of patients suffering from Sickle Cell Disease (SCD). SCD is an insidious and painful genetic blood disorder often resulting in death at an early age.

Science and Technology Minister, Turner Isoun who disclosed this in Abuja noted that location of the factory in Nigeria would further crash the price of sickle cell drugs in Nigeria.

Isoun stated that Niprisan (HEMOXIN(TM)) was a drug cocktail, with phyto-pharmaceutical composition of four traditional plants extracted in a proprietary process. The licensor of the technology is the National Institute for Pharmaceutical Research and Development (NIPRD) in Abuja, Nigeria.

Nigeria is said to have the highest sickle cell disease population in the world ranging from four to six million representing roughly three to five percent of the country's population.

Isoun spoke at the inaugural meeting of the Ministers’ Council for the National Biotechnology Development Agency (NABDA) where he also called on the government to involve more laboratories for the control and analysis of the bird flu menace.

On the situation of bio technology in Nigeria, he called on the stockholding agencies to ensure that Nigeria benefits from the judicious and safe use of modern biotechnology.

"Biotech is a gold mine and important to this nation. Almost every Nigerian is affected by the operations of biotech. To be able to achieve all these, we will require the concerted political will and a focused leadership drive. It is therefore the collective responsibility of all of us key stakeholders of modern biotechnology to join forces in realizing this vision.

It is my belief that this collective mission will not jeopardize our separate mandates but will promote the effective coordination of our effort towards achieving the same ultimate goal."

To achieve the nation’s targets in biotech, the Director General of the National Biotechnology Development Agency (NABDA), Bamidele Solomon called for the establishment of biotechnology development fund.

The fund, he stressed, could help the nation support competent researches and be ready to tackle problems like the bird flu.

He also disclosed that Nigeria in collaboration with Trinity Biotech of the Republic of Ireland will establish a facility at SHESTCO Abuja for the production of test kits for HIV/AIDS and other diseases like HB, malaria and so on.

He added that the Federal Government has approved the sum of $28 million as counterpart commitment for the project.

He also spoke of Nigeria’s collaboration with Shantha Biotechnics Limited of India for the establishment a facility for the production of Hepatitis B vaccine and other vaccines for related diseases like typhoid, polio, DTP and related ailments.

"Government approved the sum of N10 Million in the 2004 capital budget to support carrying out of a detailed feasibility study and fulfilling other MoU requirement."


More In Headlines
» Capitalisation in the insurance...
» Banks to merge for external...
» Multi-purpose halls back in...
» Obi to be sworn in today
» Delta, militants in stalemate...
» pic031706

--------------------
"Many of life's failures are people who did not realize how close they were to success when they gave up." -
 
Posted by MDP5754 on :
 
This answers a lot of Questions.

Wait for THIS RUN:

http://www.bioportfolio.com/march_05/07_03_2005/firm_plans_new_drug_for.html
 
Posted by Cerebro on :
 
Read this .....

http://www.thetidenews.com/article.aspx?qrDate=11/28/2005&qrTitle=Science%20complex%20gets%20drug%20production%20machine&qrColumn=BUSINESS
 
Posted by Cerebro on :
 
XKEM.ob ------ late 10K --- Few Days NEWS OUT !!! read Investors incredible oportunity to WIN !!!!! Dr Pandey : We have significantly expanded our operations in Nigeria over the past year. This factor has resulted in our requiring additional time and coordination in completing our disclosure. As a result of the foregoing reasons, we will not, without unreasonable effort and expense, be able to complete our Form 10-KSB within the prescribed time period. The completed filing is expected to be available within the requested fifteen day extension period. PART IV OTHER INFORMATION (1) Name and telephone number of person to contact in regard to this notification Ramesh Pandey 732-247-3300
---------------------------------



XKEM.ob ...............Great oportunity to BUY Under 0.0150 cents .HOLD HOLD HOLD this GEM ! amazing oportunity to WIN 500%.

XKEM 500mill Revs
Begining Day 1 And That Is Nigerian Govt Subsidized In Nigeria Alone!.
Their Plant To Manufacture The Drug For Sicle Cell Disease (Keeps The Effects Of The Disease Greatly Suppresed And Is The Only Known One To Do So) Is Complete And All The Supplies Are Stocked To Begin.
They Use 4 Locally Indigenous Plants In Manufacturing The Drug. They Are Awaiting Final Approval From The Nigerian Equivelent Of Our FDA Which Could Come Any Time Now. 700 Mill O/S. 30% of this his Owner ALEMBIC Big Indian Biotech.
They Just One A 4mill Settlement Against Bristol Myers Squib Also.

This Article Caught The Co By Supprise And Is Part Of The Reason For Surge In Volume. This One IS Be A Gem.
From Nigerian News Paper.>

Last Updated: 17th March


March 3rd, 2006
Obasanjo to launch locally produced sickle cell drug
E-MAIL THIS PRINT THIS


President Olusegun Obasanjo will by June launch NIPRISAN (HEMOXIN(TM)), the locally produced drug for sickle cell disorder.
PATIENCE OGBE Abuja

The president will also use the occasion to commission Xechem International Inc. factory in the country in a move seen as a landmark investment in Nigeria. The company owns the exclusive rights to NIPRISAN

The drug NIPRISAN (HEMOXIN(TM), which is at present, undergoing final stage of registration with NAFDAC is a phyto-pharmaceutical drug for the treatment of patients suffering from Sickle Cell Disease (SCD). SCD is an insidious and painful genetic blood disorder often resulting in death at an early age.

Science and Technology Minister, Turner Isoun who disclosed this in Abuja noted that location of the factory in Nigeria would further crash the price of sickle cell drugs in Nigeria.

Isoun stated that Niprisan (HEMOXIN(TM)) was a drug cocktail, with phyto-pharmaceutical composition of four traditional plants extracted in a proprietary process. The licensor of the technology is the National Institute for Pharmaceutical Research and Development (NIPRD) in Abuja, Nigeria.

Nigeria is said to have the highest sickle cell disease population in the world ranging from four to six million representing roughly three to five percent of the country's population.

Isoun spoke at the inaugural meeting of the Ministers’ Council for the National Biotechnology Development Agency (NABDA) where he also called on the government to involve more laboratories for the control and analysis of the bird flu menace.

On the situation of bio technology in Nigeria, he called on the stockholding agencies to ensure that Nigeria benefits from the judicious and safe use of modern biotechnology.

"Biotech is a gold mine and important to this nation. Almost every Nigerian is affected by the operations of biotech. To be able to achieve all these, we will require the concerted political will and a focused leadership drive. It is therefore the collective responsibility of all of us key stakeholders of modern biotechnology to join forces in realizing this vision.

It is my belief that this collective mission will not jeopardize our separate mandates but will promote the effective coordination of our effort towards achieving the same ultimate goal."

To achieve the nation’s targets in biotech, the Director General of the National Biotechnology Development Agency (NABDA), Bamidele Solomon called for the establishment of biotechnology development fund.

The fund, he stressed, could help the nation support competent researches and be ready to tackle problems like the bird flu.

He also disclosed that Nigeria in collaboration with Trinity Biotech of the Republic of Ireland will establish a facility at SHESTCO Abuja for the production of test kits for HIV/AIDS and other diseases like HB, malaria and so on.

He added that the Federal Government has approved the sum of $28 million as counterpart commitment for the project.

He also spoke of Nigeria’s collaboration with Shantha Biotechnics Limited of India for the establishment a facility for the production of Hepatitis B vaccine and other vaccines for related diseases like typhoid, polio, DTP and related ailments.

"Government approved the sum of N10 Million in the 2004 capital budget to support carrying out of a detailed feasibility study and fulfilling other MoU requirement."


More In Headlines
» Capitalisation in the insurance...
» Banks to merge for external...
» Multi-purpose halls back in...
» Obi to be sworn in today
» Delta, militants in stalemate...
» pic031706



---------------------------------
YAHOO! GROUPS LINKS


Visit your group "ENE-LONG" on the web.

To unsubscribe from this group, send an email to:
ENE-LONG-unsubscribe*yahoogroups.com

Your use of Yahoo! Groups is subject to the Yahoo! Terms of Service.
 
Posted by topsail on :
 
It's been quiet lately. Calm before the storm?
I'm holding 790K * .018 avg. and can't decide if I should average down some more. I picked up quite a bit * .016 thinking that was the bottom, but I was wrong. Whats the boards feelings?

GLTA
 
Posted by Mooby on :
 
I'm averaged to 100k at .0158, thinking about averaging down, so if you have the cash, I'd do it.

If it makes you feel any better, I picked up a bunch of my shares at .02 thinking it was a short pull-back. I was lucky enough to buy some at .01 before the burst (2/3's of which I sold for .028).

Hold on, I'm pretty sure this stock will see .03-.05 by late spring.
 
Posted by imakmony2005 on :
 
I keep adding more, This will go up big,imo
 
Posted by Cerebro on :
 
DD for new eyes: SUPER MEGA BUY CONFIRMED !!!!!!!!!!

XKEm.ob ----- High Recommend Investment ---- Buy Confirmed ------- Easy 0.10 cents --WIN 500%---- Read this

We began to put XKEm.ob on

HIGH RECOMENDATION ....!!!!!!!

after publication of the March 3, 2006 article
by Patience Ogbe in the BusinessDay ----

http://www.businessdayonline.com/?c=44&a=4926

That is the article in which Turner Isoun is quoted as saying that President Obasanjo will commission the Xechem factory and launch NIPRISAN (NICOSAN TM) "by June." Questions have arisen as to the authenticiy of those quotes by Mr. Isoun.

The linked article from Vanguard (posted to the web on July 14, 2005) http://www.vanguardngr.com/articles/2002/business/july05/14072005/b414072005.htm l

was written by Peter Egwuatu, a reputable journalist who writes about business matters in Nigeria.

Mr. Egwuatu quotes not only Mr. Isoun (who recommends that Nigerians invest in Xechem), but also President Obasanjo (who praises Xechem and NICOSAN).

Reading these articles together, I believe that it is clearly a question of "when," not "whether," NICOSAN will be registered by NAFDAC and launched at the SHESTCO facility.

http://www.shestco.org/tech_park.htm

These articles are also consistent with the view that Nigeria will be involved in the financing of NICOSAN's launch. The day of announce is this .....

http://www-scf.usc.edu/~odujinri/

I have never before owned a stock that was so openly recommended as an investment by the national government.
Folks, registration by NAFDAC is a done deal.

Another Links . About XKEM

http://www.businessdayonline.com/?c=44&a=4926

http://www.vanguardngr.com/articles/2002/business/july05/14072005/b414072005.htm l

http://www.amsterdamnews.org/News/article/article.asp?NewsID=65096&sID=20

http://www-scf.usc.edu/~odujinri/

http://www.thetidenews.com/article.aspx?qrTitle=Nigeria%20has%20highest%20sickle -cell%20patients%20worldwide%20%20-%20%20Xechem&qrDate=9/8/2005&qrColumn=NEWS

http://www.shestco.org/tech_park.htm

http://www.nb4s.********.com/

http://biz.yahoo.com/bw/060125/20060125005121.html?.v=1
 
Posted by Stockstar69 on :
 
I was able to double my position in this today. We just need it to go up, up, and away.
 
Posted by kittykash on :
 
I do believe it's time to buy in again, if you are out of it.
 
Posted by kittykash on :
 
Apr 04, 2006 (M2 PRESSWIRE via COMTEX) -- www.**********, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold lists: Tower Automotive, Inc. (TWRAQ), Xechem International, Inc. (XKEM), Ceragenix Pharmaceuticals, Inc. (CGXP), Chelsea Therapeutics International, Ltd. (CHTP), IceWEB, Inc. (IWEB), Lexington Resources, Inc. (LXRS). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.**********.
 
Posted by kittykash on :
 
The company has operations in the United States, India, China, and Nigeria. Xechem International was founded in 1994 by Ramesh C. Pandey and is headquartered in New Brunswick, New Jersey. With 259.69 million shares outstanding and an undisclosed short position, there is no longer a failure to deliver in shares of XKEM.
 
Posted by kittykash on :
 
buy confirmed today in *************.
 
Posted by Cerebro on :
 
www.xechemnigeria.org ------- up april 7
 
Posted by Cerebro on :
 
XKEm.ob --www.xechemnigeria.org ----- Start Today ------------- OFICIAL NEWS OUT SOON -------- High Recommend Investment ---- Buy Confirmed ------- Easy 0.10 cents ------ Read this registration by NAFDAC is a done deal.

We began to put XKEm.ob on

HIGH RECOMENDATION ....!!!!!!!

after publication of the March 3, 2006 article
by Patience Ogbe in the BusinessDay ----

http://www.businessdayonline.com/?c=44&a=4926

That is the article in which Turner Isoun is quoted as saying that President Obasanjo will commission the Xechem factory and launch NIPRISAN (NICOSAN TM) "by June." Questions have arisen as to the authenticiy of those quotes by Mr. Isoun.

The linked article from Vanguard (posted to the web on July 14, 2005) http://www.vanguardngr.com/articles/2002/business/july05/14072005/b414072005.htm l

was written by Peter Egwuatu, a reputable journalist who writes about business matters in Nigeria.

Mr. Egwuatu quotes not only Mr. Isoun (who recommends that Nigerians invest in Xechem), but also President Obasanjo (who praises Xechem and NICOSAN).

Reading these articles together, I believe that it is clearly a question of "when," not "whether," NICOSAN will be registered by NAFDAC and launched at the SHESTCO facility.


http://www.shestco.org/tech_park.htm

www.xechemnigeria.org


These articles are also consistent with the view that Nigeria will be involved in the financing of NICOSAN's launch. The day of announce is this .....

http://www-scf.usc.edu/~odujinri/

I have never before owned a stock that was so openly recommended as an investment by the national government.
Folks, registration by NAFDAC is a done deal.

Another Links . About XKEM

http://www.businessdayonline.com/?c=44&a=4926

http://www.vanguardngr.com/articles/2002/business/july05/14072005/b414072005.htm l

http://www.amsterdamnews.org/News/article/article.asp?NewsID=65096&sID=20

http://www-scf.usc.edu/~odujinri/


http://www.thetidenews.com/article.aspx?qrTitle=Nigeria%20has%20highest%20sickle -cell%20patients%20worldwide%20%20-%20%20Xechem&qrDate=9/8/2005&qrColumn=NEWS

http://www.shestco.org/tech_park.htm

http://www.nb4s.********.com/

http://biz.yahoo.com/bw/060125/20060125005121.html?.v=1

12">http://www.**********/tools/short_list.php?dys=>12


[Non-text portions of this message have been removed]


[Non-text portions of this message have been removed]


--------------------------------------------------------------------------------
YAHOO! GROUPS LINKS

Visit your group "forex_inside_trader" on the web.

To unsubscribe from this group, send an email to:
forex_inside_trader-unsubscribe*yahoogroups.com

Your use of Yahoo! Groups is subject to the Yahoo! Terms of Service.


--------------------------------------------------------------------------------
 
Posted by Stockstar69 on :
 
GOOD NEWS! Finally.
 
Posted by kittykash on :
 
I've been looking for the news in ameritrade, it's not showing anything. Volume is wonderful today, must list news somewhere??
 
Posted by topsail on :
 
I haven't found any news at all. Not complaining with today's action, but must admit, I'm confused. Anyone have anything?
 
Posted by Stockstar69 on :
 
Sorry if I confused anyone. I didn't see any news, I just meant I thought it was good news to see the stock going up.

My apologies.
 
Posted by QBID'n on :
 
quote:
Originally posted by Cerebro:
XKEM.ob ------ late 10K --- Few Days NEWS OUT !!! read Investors incredible oportunity to WIN !!!!! Dr Pandey : We have significantly expanded our operations in Nigeria over the past year. This factor has resulted in our requiring additional time and coordination in completing our disclosure. As a result of the foregoing reasons, we will not, without unreasonable effort and expense, be able to complete our Form 10-KSB within the prescribed time period. The completed filing is expected to be available within the requested fifteen day extension period. PART IV OTHER INFORMATION (1) Name and telephone number of person to contact in regard to this notification Ramesh Pandey 732-247-3300

Volume may be due to the 10k expectation. jmo

Don't own, but wish you guys luck.
 
Posted by topsail on :
 
Stock and this board have been pretty quiet. Hopefully when the 10-ksb is released, they'll have some updates to report. Holding 675K shares and waiting for news.

GLTA
 
Posted by topsail on :
 
ok, fellow board members. whats the take on the 10-ksb? I haven't decided if I'm going to buy more on this latest drop. I'll probably sit on the sidelines today and just watch the action.

GLTA
 
Posted by imakmony2005 on :
 
bump
 
Posted by imakmony2005 on :
 
going over .02 imo
 
Posted by imakmony2005 on :
 
Good old DD ON THIS OLD THREAD.
 
Posted by Peaser01 on :
 
Sure is monkey.
 
Posted by Peaser01 on :
 
http://www.businessdayonline.com/?c=44&a=4926
 
Posted by BooDog on :
 
Shantha Biotechnics Limited is also doing well there but I can't find any investment op.
 


© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2